 |
Cys-His-Ala-Val-Cys |
|---|---|
| Trade Name | |
| Orphan Indication | For use in conjunction with melphalen for the treatment of malignant melanoma, AJCC stages IIB, IIC, III and IV |
| USA Market Approval | USA |
| USA Designation Date | 2008-02-14 00:00:00 |
| Sponsor | Adherex Technologies, Inc.;4620 Creekstone Drive;Durham, North Carolina, 27703 |
